Fate therapeutics to present at upcoming may investor conferences

San diego, may 06, 2022 (globe newswire) -- fate therapeutics, inc. (the “company” or “fate therapeutics”) (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the company will present at the following upcoming investor conferences:

FATE Ratings Summary

FATE Quant Ranking